
Also known as CJC/Ipa blend
For In Vitro Use Only — Not for Human Use
Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.
Combined vial — CJC-1295 without DAC (Mod GRF 1-29) 10mg with Ipamorelin 10mg, lyophilised at ≥98% purity for in vitro growth-hormone-axis research. Coming soon.
This combined vial pairs CJC-1295 without DAC (Modified GRF 1-29) 10mg with Ipamorelin 10mg — the standard blend referenced in growth-hormone-axis research. Supplied as a lyophilised powder for laboratory research use only.
CJC-1295 is a GHRH analogue acting at the GHRH receptor; Ipamorelin is a selective ghrelin-receptor (GHS-R1a) agonist. Because the two act on complementary receptors within the same axis, the blend is used to model additive receptor signalling in vitro without the confounding cortisol/prolactin effects seen with older, non-selective secretagogues.